Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Stomach Neoplasms 8Lymphoma, B-Cell, Marginal Zone 5Gastritis 5Lymphoma 4Dyspepsia 4Peptic Ulcer 3Neoplasms 2Stomach Ulcer 1Skin Neoplasms 1Pseudomyxoma Peritonei 1Precancerous Gastric Lesions 1Neutropenia 1Neoplasms, Plasma Cell 1Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Infections 1Hematologic Neoplasms 1Helicobacter Infections 1Head and Neck Neoplasms 1Glioblastoma 1Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1Fever 1Familial primary gastric lymphoma 1Drug-Related Side Effects and Adverse Reactions 1Cystectomy 1Chemotherapy Effect 1Brain Neoplasms 1

Interventions

Proton Pump Inhibitors 2Vitamin D 1Therapeutics 1Rabeprazole 1Probiotics 1Pantoprazole 1Observation 1Lansoprazole 1Dexlansoprazole 1Clarithromycin 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Helicobacter Infections × Amoxicillin × Clear all
NCT07293910 2026-02-13

Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection

Tanta University

Phase 2 Recruiting
66 enrolled

Helicobacter Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡